Isaac Majors1, Vivek S Jagadale2. 1. Department of Orthopedic Surgery, Central Arkansas Veterans Healthcare System, University of Arkansas College of Medicine, 4300 West 7th St, Little Rock, AR, 72205, USA. 2. Department of Orthopedic Surgery, Central Arkansas Veterans Healthcare System, University of Arkansas College of Medicine, 4300 West 7th St, Little Rock, AR, 72205, USA. vsjagadale@uams.edu.
Abstract
BACKGROUND: Accurate preoperative diagnosis of prosthetic joint infection (PJI) in the absence of obvious clinical signs or laboratory findings is challenging. Interleukin 6 (IL-6) has been proposed as an infection marker but supportive data are limited. We studied the diagnostic utility of serum IL-6 in infected total knee arthroplasty (TKA). METHODS: A prospective cohort study was done in 52 patients (59 knees) with a painful TKA. The abnormal limits for serum IL-6, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), synovial fluid white cell counts (WBC) and synovial fluid neutrophils (PMN) were determined from receiver operating characteristic curves. An infection was defined as the presence of sinus tract or positive culture > two separate tissue or fluid samples. We utilized Mann-Whitney test, Spearman's correlation and Fischer's exact test to determine the sensitivity, specificity, positive predictive value, negative predictive value (NPV) and accuracy of serum IL-6. RESULTS: The optimal threshold concentration of serum IL-6 was 9.14 pg/ml. Independently, this yielded a sensitivity, specificity and NPV of 81%, 63% and 85%, respectively, and when combined with synovial fluid WBC, values were 100%, 90%, 100%, respectively. The sensitivity and specificity of ESR (70%, 63.6%), CRP (66.7%, 66.7%), synovial WBC (66.7%, 81%) and synovial PMN (82.4%, 73.7%) were also calculated. Serum IL-6 levels strongly correlate with all markers in PJI. CONCLUSIONS: Serum IL-6 improves the diagnosis of PJI over existing methods, especially when combined with synovial fluid WBC. Its optimal usage is as an excellent screening test to rule out infected total knee arthroplasty. LEVEL OF EVIDENCE: Diagnostic Level II.
BACKGROUND: Accurate preoperative diagnosis of prosthetic joint infection (PJI) in the absence of obvious clinical signs or laboratory findings is challenging. Interleukin 6 (IL-6) has been proposed as an infection marker but supportive data are limited. We studied the diagnostic utility of serum IL-6 in infected total knee arthroplasty (TKA). METHODS: A prospective cohort study was done in 52 patients (59 knees) with a painful TKA. The abnormal limits for serum IL-6, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), synovial fluid white cell counts (WBC) and synovial fluid neutrophils (PMN) were determined from receiver operating characteristic curves. An infection was defined as the presence of sinus tract or positive culture > two separate tissue or fluid samples. We utilized Mann-Whitney test, Spearman's correlation and Fischer's exact test to determine the sensitivity, specificity, positive predictive value, negative predictive value (NPV) and accuracy of serum IL-6. RESULTS: The optimal threshold concentration of serum IL-6 was 9.14 pg/ml. Independently, this yielded a sensitivity, specificity and NPV of 81%, 63% and 85%, respectively, and when combined with synovial fluid WBC, values were 100%, 90%, 100%, respectively. The sensitivity and specificity of ESR (70%, 63.6%), CRP (66.7%, 66.7%), synovial WBC (66.7%, 81%) and synovial PMN (82.4%, 73.7%) were also calculated. Serum IL-6 levels strongly correlate with all markers in PJI. CONCLUSIONS: Serum IL-6 improves the diagnosis of PJI over existing methods, especially when combined with synovial fluid WBC. Its optimal usage is as an excellent screening test to rule out infected total knee arthroplasty. LEVEL OF EVIDENCE: Diagnostic Level II.
Entities:
Keywords:
Interleukin 6; Prosthetic joint infection; Total knee arthroplasty
Authors: M Honda; K Kitamura; Y Mizutani; M Oishi; M Arai; T Okura; K Igarahi; K Yasukawa; T Hirano; T Kishimoto Journal: J Immunol Date: 1990-12-15 Impact factor: 5.422
Authors: Elie Berbari; Tad Mabry; Geoffrey Tsaras; Mark Spangehl; Pat J Erwin; Mohammad Hassan Murad; James Steckelberg; Douglas Osmon Journal: J Bone Joint Surg Am Date: 2010-09-01 Impact factor: 5.284
Authors: Matthew P Abdel; Doruk Akgün; George Akin; Bolarinwa Akinola; Paulo Alencar; Derek F Amanatullah; Sina Babazadeh; Olivier Borens; Rui Manuel Vicente Cabral; Kyle H Cichos; Carl Deirmengian; Richard de Steiger; Elie Ghanem; João Rodolfo Radtke Gonçalves; Stuart Goodman; Brian Hamlin; Katherine Hwang; Brian A Klatt; Gwo-Chin Lee; Jorge Manrique; Andrew S Moon; Felix Ogedegbe; C G Salib; Shaoqi Tian; Tobias Winkler Journal: J Arthroplasty Date: 2018-10-19 Impact factor: 4.757
Authors: Bernd Kubista; Robert U Hartzler; Christina M Wood; Douglas R Osmon; Arlen D Hanssen; David G Lewallen Journal: Int Orthop Date: 2011-05-07 Impact factor: 3.075
Authors: Carl A Deirmengian; Patrick A Citrano; Simmi Gulati; Erick R Kazarian; James W Stave; Keith W Kardos Journal: J Arthroplasty Date: 2016-03-15 Impact factor: 4.757
Authors: Thomas Ackmann; Burkhard Möllenbeck; Georg Gosheger; Jan Schwarze; Tom Schmidt-Braekling; Kristian Nikolaus Schneider; Adrien Frommer; Ralf Dieckmann; Christoph Theil Journal: J Clin Med Date: 2020-09-10 Impact factor: 4.241